Trulieve Cannabis Corp. (TRLV) stock
TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3033% below fair value
$10.33−0.57 (-5.23%)
Close on Nov 16, 2026Market cap $1.99BP/E –Yield –
Trulieve Cannabis r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Trulieve Cannabis
Trulieve Cannabis has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?